Review ArticlesIntroduction by the Guest Editor Oligometastatic Disease in CancerKim, Hyun S. MD*,†,‡Author Information From the *Section of Interventional Radiology, Department of Radiology and Biomedical Imaging †Section of Medical Oncology, Department of Internal Medicine ‡Yale Cancer Center, Yale School of Medicine, New Haven, CT. Conflicts of Interest and Source of Funding: H.S.K. served on Advisory boards for Boston Scientific, SIRTex, Genentech, Eisai, Amgen, and Bayer and received research support from Galil and Flatiron. The other authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article. H.S.K. is supported by the US Department of Defense (CA160741). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Reprints: Hyun S. Kim, MD, Yale Cancer Center, Yale School of Medicine, 330 Cedar St, PO Box 208042, New Haven, CT 06520. E-mail: firstname.lastname@example.org. The Cancer Journal: March/April 2020 - Volume 26 - Issue 2 - p 95 doi: 10.1097/PPO.0000000000000443 Buy Metrics Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.